Case of Mycobacterium marinum infection with unusual patterns of susceptibility to commonly used antibiotics

Journal of Clinical Microbiology

Volumn 49, Issue 5, 2011, Pages 2056-2058

  Parrish, Nicole ^a   Luethke, Ronald ^a   Dionne, Kim ^a   Carroll, Karen ^a   Riedel, Stefan ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ETHAMBUTOL; FLUOCINONIDE; PSEUDOMONIC ACID; RIFAMPICIN; RNA 16S;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CASE REPORT; ERYTHEMA; HAND INJURY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM MARINUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS; RASH; SKIN BIOPSY;

ANTI-BACTERIAL AGENTS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM;

MYCOBACTERIUM MARINUM;

EID: 79955525722     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02022-10     Document Type: Article

References (21)

1. Aubry, A., V. Jarlier, S. Escolano, C. Truffot-Pernot, and E. Cambau. 2000. Antibiotic susceptibility pattern of Mycobacterium marinum. Antimicrob. Agents Chemother. 44:3133-3136.
2. Aubry, A., O. Chosidow, E. Caumes, J. Robert, and E. Cambau. 2002. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment and antibiotic susceptibility of causative isolates. Arch. Intern. Med. 162:1746-1752.
3. Barton, A., R. Bernstein, J. Struthers, and T. O'Neill. 1997. Mycobacterium marinum infection causing septic arthritis and osteomyelitis. Br. J. Rheumatol. 36:1207-1209.
4. Brown, B. A., and R. J. Wallace. 2000. Infections due to nontuberculous mycobacteria, p. 2630-2636. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th edition. Churchill Livingstone, Philadelphia, PA.
5. CLSI/NCCLS. 2003. Susceptibility testing of Mycobacteria, Nocardiae and other aerobic Actinomycetes, approved standard M24-A, vol. 23, p. 18. National Committee for Clinical Laboratory Standards, Wayne, PA.
6. Ekerot, L., L. Jacobsson, and A. Forsgren. 1998. Mycobacterium marinum wrist arthritis: local and systemic dissemination caused by concomitant immunosuppressive therapy. Scand. J. Infect. Dis. 30:84-87.
7. Gluckman, S. J. 1995. Mycobacterium marinum. Clin. Dermatol. 13:273-276.
8. Gould, C., V. P. Werth, and S. Gluckman. 2004. Fatal disseminated Mycobacterium marinum infection with bacteremia in a patient misdiagnosed as pyoderma gangrenosum. Infect. Dis. Clin. Pract. 12:26-29.
9. Ho, P. L., et al. 2001. A case of disseminated Mycobacterium marinum infection following systemic steroid therapy. Scand. J. Infect. Dis. 33:232-233.
10. Kumar, A., N. Grewal, H. Katchikian, and N. Jones. 2008. Complex Mycobacterium marinum hand infections: case reports and review of literature. Infect. Dis. Clin. Pract. 16:278-282.
11. Manjusha, S., G. B. Sarita, K. K. Elyas, and M. Chandrasekaran. 2005. Multiple antibiotic resistances of Vibrio isolates from coastal and brackish water areas. Am. J. Biochem. Biotech. 1:201-206.
12. Runyon, E. 1959. Anonymous mycobacteria in pulmonary disease. Med. Clin. North Am. 43:273-290.
13. Sanders, W., and E. Wolinksky. 1980. In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents. Antimicrob. Agents Chemother. 18:529-531.
14. Streit, S., et al. 2006. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur. J. Dermatol. 16:79-83.
15. Torres, J., M. Sands, and C. Sanders. 1978. In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline. Tubercle 59:193-195.
16. Wallace, R. J., and K. Wiss. 1981. Susceptibility of Mycobacterium marinum to tetracyclines and aminoglycosides. Antimicrob. Agents Chemother. 20:610-612.
17. Wallace, R. J., Jr., et al. 1997. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. American Thoracic Society Statement. Am. J. Respir. Crit. Care Med. 156:S1-S25.
18. Wolinksky, E. 1979. Nontuberculous mycobacteria and associated diseases. Am. Rev. Respir. Dis. 119:107-159.
19. Woodley, C. L., J. Kilburn, H. L. David, and V. A. Silcox. 1972. Susceptibility of mycobacteria to rifampin. Antimicrob. Agents Chemother. 2:245-249.
20. Wu, T., et al. 2002. Mycobacterium marinum infection in Taiwan. J. Microbiol. Immunol. Infect. 35:42-46.
21. Zenone, T., et al. 1999. Non-tuberculous mycobacterial tenosynovitis: a review. Scand. J. Infect. Dis. 31:221-228.